相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Coptisine from Rhizoma Coptidis Suppresses HCT-116 Cells-related Tumor Growth in vitro and in vivo
Tao Huang et al.
SCIENTIFIC REPORTS (2017)
Cancer Statistics, 2016
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Global Cancer Statistics, 2012
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
Genetics and Biology of Pancreatic Ductal Adenocarcinoma
Richard F. Dunne et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2015)
Suppression of Human Breast Cancer Cell Metastasis by Coptisine in Vitro
Jing Li et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)
Effect of Furin inhibitor on lung adenocarcinoma cell growth and metastasis
Yong-Chao Ma et al.
CANCER CELL INTERNATIONAL (2014)
Targeting RAS-ERK signalling in cancer: promises and challenges
Ahmed A. Samatar et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Rasfonin, a novel 2-pyrone derivative, induces ras-mutated Panc-1 pancreatic tumor cell death in nude mice
Z. Xiao et al.
CELL DEATH & DISEASE (2014)
Ellagic acid inhibits human pancreatic cancer growth in Balb c nude mice
Min Zhao et al.
CANCER LETTERS (2013)
Targeting the RAF-MEK-ERK pathway in cancer therapy
Clara Montagut et al.
CANCER LETTERS (2009)
Delphinidin, an Anthocyanidin in Pigmented Fruits and Vegetables, Induces Apoptosis and Cell Cycle Arrest in Human Colon Cancer HCT116 Cells
Jung-Mi Yun et al.
MOLECULAR CARCINOGENESIS (2009)
Surgical Treatment of Pancreatic Cancer
Martin Loos et al.
RECENT ADVANCES IN CLINICAL ONCOLOGY (2008)
Silibinin inhibits colorectal cancer growth by inhibiting tumor cell proliferation and angiogenesis
Rana P. Singh et al.
CANCER RESEARCH (2008)
Advances in targeting the Ras/Raf/MEK/Erk mitogen-activated protein kinase cascade with MEK inhibitors for cancer therapy
Bret B. Friday et al.
CLINICAL CANCER RESEARCH (2008)
Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer
P. J. Roberts et al.
ONCOGENE (2007)
Oral Silibinin inhibits lung tumor growth in athymic nude mice and forms a novel chemocombination with doxorubicin targeting nuclear factor κB-mediated inducible chemoresistance
RP Singh et al.
CLINICAL CANCER RESEARCH (2004)
Multicomponent analysis of the pancreatic adenocarcinoma progression model using a pancreatic intraepithelial neoplasia tissue microarray
A Maitra et al.
MODERN PATHOLOGY (2003)
New applications of gemcitabine and future directions in the management of pancreatic cancer
JL Abbruzzese
CANCER (2002)
分享论文
